These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 28068325)

  • 21. NSD1 mediates antagonism between SWI/SNF and polycomb complexes and is required for transcriptional activation upon EZH2 inhibition.
    Drosos Y; Myers JA; Xu B; Mathias KM; Beane EC; Radko-Juettner S; Mobley RJ; Larsen ME; Piccioni F; Ma X; Low J; Hansen BS; Peters ST; Bhanu NV; Dhanda SK; Chen T; Upadhyaya SA; Pruett-Miller SM; Root DE; Garcia BA; Partridge JF; Roberts CWM
    Mol Cell; 2022 Jul; 82(13):2472-2489.e8. PubMed ID: 35537449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of tumor suppressor KDM6A amplifies PRC2-regulated transcriptional repression in bladder cancer and can be targeted through inhibition of EZH2.
    Ler LD; Ghosh S; Chai X; Thike AA; Heng HL; Siew EY; Dey S; Koh LK; Lim JQ; Lim WK; Myint SS; Loh JL; Ong P; Sam XX; Huang D; Lim T; Tan PH; Nagarajan S; Cheng CW; Ho H; Ng LG; Yuen J; Lin PH; Chuang CK; Chang YH; Weng WH; Rozen SG; Tan P; Creasy CL; Pang ST; McCabe MT; Poon SL; Teh BT
    Sci Transl Med; 2017 Feb; 9(378):. PubMed ID: 28228601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting the enhancer of zeste homologue 2 in medulloblastoma.
    Alimova I; Venkataraman S; Harris P; Marquez VE; Northcott PA; Dubuc A; Taylor MD; Foreman NK; Vibhakar R
    Int J Cancer; 2012 Oct; 131(8):1800-9. PubMed ID: 22287205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A partially disordered region connects gene repression and activation functions of EZH2.
    Jiao L; Shubbar M; Yang X; Zhang Q; Chen S; Wu Q; Chen Z; Rizo J; Liu X
    Proc Natl Acad Sci U S A; 2020 Jul; 117(29):16992-17002. PubMed ID: 32631994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Polycomb group protein EZH2 directly controls DNA methylation.
    Viré E; Brenner C; Deplus R; Blanchon L; Fraga M; Didelot C; Morey L; Van Eynde A; Bernard D; Vanderwinden JM; Bollen M; Esteller M; Di Croce L; de Launoit Y; Fuks F
    Nature; 2006 Feb; 439(7078):871-4. PubMed ID: 16357870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new kinetochore component CENP-W interacts with the polycomb-group protein EZH2 to promote gene silencing.
    Koh W; Park B; Lee S
    Biochem Biophys Res Commun; 2015 Aug; 464(1):256-62. PubMed ID: 26111449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PRC2 and SWI/SNF Chromatin Remodeling Complexes in Health and Disease.
    Kadoch C; Copeland RA; Keilhack H
    Biochemistry; 2016 Mar; 55(11):1600-14. PubMed ID: 26836503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of OGT deregulation on EZH2 target genes FOXA1 and FOXC1 expression in breast cancer cells.
    Forma E; Jóźwiak P; Ciesielski P; Zaczek A; Starska K; Bryś M; Krześlak A
    PLoS One; 2018; 13(6):e0198351. PubMed ID: 29864144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tripartite motif containing 28 (TRIM28) promotes breast cancer metastasis by stabilizing TWIST1 protein.
    Wei C; Cheng J; Zhou B; Zhu L; Khan MA; He T; Zhou S; He J; Lu X; Chen H; Zhang D; Zhao Y; Fu J
    Sci Rep; 2016 Jul; 6():29822. PubMed ID: 27412325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EZH2 activates CHK1 signaling to promote ovarian cancer chemoresistance by maintaining the properties of cancer stem cells.
    Wen Y; Hou Y; Yi X; Sun S; Guo J; He X; Li T; Cai J; Wang Z
    Theranostics; 2021; 11(4):1795-1813. PubMed ID: 33408782
    [No Abstract]   [Full Text] [Related]  

  • 31. EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis.
    Cheng AS; Lau SS; Chen Y; Kondo Y; Li MS; Feng H; Ching AK; Cheung KF; Wong HK; Tong JH; Jin H; Choy KW; Yu J; To KF; Wong N; Huang TH; Sung JJ
    Cancer Res; 2011 Jun; 71(11):4028-39. PubMed ID: 21512140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epigenetic regulation of cell adhesion and communication by enhancer of zeste homolog 2 in human endothelial cells.
    Dreger H; Ludwig A; Weller A; Stangl V; Baumann G; Meiners S; Stangl K
    Hypertension; 2012 Nov; 60(5):1176-83. PubMed ID: 22966008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EZH2 promotes expansion of breast tumor initiating cells through activation of RAF1-β-catenin signaling.
    Chang CJ; Yang JY; Xia W; Chen CT; Xie X; Chao CH; Woodward WA; Hsu JM; Hortobagyi GN; Hung MC
    Cancer Cell; 2011 Jan; 19(1):86-100. PubMed ID: 21215703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Downregulation of Ezh2 methyltransferase by FOXP3: new insight of FOXP3 into chromatin remodeling?
    Shen Z; Chen L; Yang X; Zhao Y; Pier E; Zhang X; Yang X; Xiong Y
    Biochim Biophys Acta; 2013 Oct; 1833(10):2190-200. PubMed ID: 23688634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hsp90α Mediates BMI1 Expression in Breast Cancer Stem/Progenitor Cells through Facilitating Nuclear Translocation of c-Myc and EZH2.
    Lee YC; Chang WW; Chen YY; Tsai YH; Chou YH; Tseng HC; Chen HL; Wu CC; Chang-Chien J; Lee HT; Yang HF; Wang BY
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28914785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EZH2 promotes colorectal cancer stem-like cell expansion by activating p21cip1-Wnt/β-catenin signaling.
    Chen JF; Luo X; Xiang LS; Li HT; Zha L; Li N; He JM; Xie GF; Xie X; Liang HJ
    Oncotarget; 2016 Jul; 7(27):41540-41558. PubMed ID: 27172794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The gene encoding the prostatic tumor suppressor PSP94 is a target for repression by the Polycomb group protein EZH2.
    Beke L; Nuytten M; Van Eynde A; Beullens M; Bollen M
    Oncogene; 2007 Jul; 26(31):4590-5. PubMed ID: 17237810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interactomic analysis of REST/NRSF and implications of its functional links with the transcription suppressor TRIM28 during neuronal differentiation.
    Lee N; Park SJ; Haddad G; Kim DK; Park SM; Park SK; Choi KY
    Sci Rep; 2016 Dec; 6():39049. PubMed ID: 27976729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methylation of EZH2 by PRMT1 regulates its stability and promotes breast cancer metastasis.
    Li Z; Wang D; Lu J; Huang B; Wang Y; Dong M; Fan D; Li H; Gao Y; Hou P; Li M; Liu H; Pan ZQ; Zheng J; Bai J
    Cell Death Differ; 2020 Dec; 27(12):3226-3242. PubMed ID: 32895488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancer of Zeste 2 (EZH2) is up-regulated in malignant gliomas and in glioma stem-like cells.
    Orzan F; Pellegatta S; Poliani PL; Pisati F; Caldera V; Menghi F; Kapetis D; Marras C; Schiffer D; Finocchiaro G
    Neuropathol Appl Neurobiol; 2011 Jun; 37(4):381-94. PubMed ID: 20946108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.